Inventor · disambiguated record
James Francis Mccabe
Also filed as: MCCABE JAMES · MCCABE JAMES F · MCCABE JAMES FRANCIS
17 granted patents·4 pending applications·204 citations·filing 1999–2022
93Inventor score
Files withASTRAZENECA AB13DIZAL JIANGSU PHARMACEUTICAL CO LTD4FORD JAMES GAIR1MCCABE JAMES1MERCK SHARP & DOHME1
Top patents by PatentIndex Score
21 records- 0190US7148230B2Quinazoline derivativesASTRAZENECA AB·Filed 2004·Granted Dec 12, 2006·42 cites·5 claims
- 0287US7696191B2Crystalline compoundASTRAZENECA AB·Filed 2007·Granted Apr 13, 2010·13 cites·9 claims
- 0387US6453216B1Method of controlling an irrigation systemFiled 1999·Granted Sep 17, 2002·108 cites·10 claims
- 0486US11247983B2Compounds and methods for inhibiting JAKDIZAL JIANGSU PHARMACEUTICAL CO LTD·Filed 2020·Granted Feb 15, 2022·2 cites·19 claims
- 0586US10167276B2Compounds and methods for inhibiting JAKDIZAL JIANGSU PHARMACEUTICAL CO LTD·Filed 2017·Granted Jan 1, 2019·5 cites·5 claims
- 0686US9944650B2[1,2,4]triazolo[4,3-B]pyridazines for use in the treatment of proliferative diseasesASTRAZENECA AB·Filed 2015·Granted Apr 17, 2018·5 cites·8 claims
- 0784US10654835B2Compounds and methods for inhibiting JAKDIZAL JIANGSU PHARMACEUTICAL CO LTD·Filed 2018·Granted May 19, 2020·3 cites·22 claims
- 0883US10766905B2[1,2,4]triazolo[4,3-B]pyridazines for use in the treatment of proliferative diseasesASTRAZENECA AB·Filed 2019·Granted Sep 8, 2020·1 cites·8 claims
- 0983US10407432B2[1,2,4]triazolo[4,3-B]pyridazines for use in the treatment of proliferative diseasesASTRAZENECA AB·Filed 2018·Granted Sep 10, 2019·3 cites·8 claims
- 1083US8859570B2Maleate salts of a quinazoline derivative useful as an antiangiogenic agentMCCABE JAMES·Filed 2009·Granted Oct 14, 2014·8 cites·11 claims
- 1177US9902731B2Chemical compoundsASTRAZENECA AB·Filed 2016·Granted Feb 27, 2018·2 cites·19 claims
- 1275US12319670B2Compounds and methods for inhibiting JAKDIZAL JIANGSU PHARMACEUTICAL CO LTD·Filed 2021·Granted Jun 3, 2025·0 cites·24 claims
- 1370US2023035133A1[1,2,4]Triazolo[4,3-B]Pyridazines For Use in the Treatment of Proliferative DiseasesASTRAZENECA AB·Filed 2022·Application pending·0 cites
- 1466US11407755B2[1,2,4]triazolo[4,3-b]pyridazines for use in the treatment of proliferative diseasesASTRAZENECA AB·Filed 2020·Granted Aug 9, 2022·0 cites·15 claims
- 1564US2019375730A1Maleate salts of a quinazoline derivative useful as an antiangiogenic agentASTRAZENECA AB·Filed 2019·Application pending·0 cites
- 1661US2018170913A1Maleate salts of a quinazoline derivative useful as an antiangiogenic agentASTRAZENECA AB·Filed 2017·Application pending·0 cites
- 1759US11149029B2Salts of IJAK inhibitors and methods of using the sameASTRAZENECA AB·Filed 2019·Granted Oct 19, 2021·0 cites·12 claims
- 1855US10202391B2Chemical compoundsASTRAZENECA AB·Filed 2018·Granted Feb 12, 2019·0 cites·3 claims
- 1955US6630471B1Substituted triazolo-pyridazine derivative, pharmaceutical compositions made therefromMERCK SHARP & DOHME·Filed 1999·Granted Oct 7, 2003·12 cites·6 claims
- 2045US2007099943A1Quinazoline derivativesASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2136US8304417B2Crystalline forms of 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazolineFORD JAMES GAIR·Filed 2005·Granted Nov 6, 2012·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when James Francis Mccabe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →